Development of Therapeutic Products for Antibiotic Resistant Bacteria
- Institution
- CRESTONE, INC., CO
- Principal investigator
- Urs Arnold Ochsner
- Funding
- $1.6M
- Duration
- 2020–2025
Moonbase score
Still being scored
Abstract
To support the advanced development of candidate therapeutics for biodefense pathogens or emerging infectious diseases. The supported research and development activities will progress the therapeutic product development and may include lead optimization, candidate selection, preclinical and IND enabling studies, Chemistry, Manufacturing, and Controls (CMC), IND submission, clinical safety and efficacy assessment.
LOADING MOONBASE SCORE
Questions for Crestone, Inc.
Crestone, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same institution, same topic, scored first.
- NIH · Crestone, Inc.Not yet scored
Development of Therapeutic Products for Antibacterial Resistant Infections
Urs Oschner · $3.9M · 2019–2026
- NIH · Duke UniversityNot yet scored
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
Kevin Saunders · $99K · 2022–2026
- NIH · Immunartes LlcNot yet scored
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
Vilasack Thammavongsa · $211K · 2022–2027